Back to search

Article

An Immune-Related Clinical-Gene-Risk-Score (CGRS) prognosis Model for Bladder Cancer

2022-09-20

Abstract excerpt

<h4>Background: </h4> Immunotherapy for bladder cancer is prevalent, while efficacy is uncertain. To predict the outcomes of immunotherapy in bladder cancer patients, an immune-related prognosis model was conducted in this study. <h4>Methods: </h4> Single sample Gene Set Enrichment Analysis was used to delineate the landscape of the tumor immune microenvironment based on two independent public databases. Hierarch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c60f942c-3b11-56ac-98d8-86455dcd72e7
DOI
10.21203/rs.3.rs-1397810/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Immune-Related Clinical-Gene-Risk-Score (CGRS) prognosis Model for Bladder CancerDOI 10.21203/rs.3.rs-1397810/v3
Select a neighboring publication to make it the new centre.